Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review.

We aimed to summarize the evidence examining factors that predict differential response to mycophenolate mofetil (MMF) in systemic lupus erythematosus (SLE).